Skip to main content

Forearm Fracture

2
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
1
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 3 programs with unclassified modality

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Sandoz
SandozAustria - Kundl
1 program
1
Salmon calcitoninPhase 41 trial
Active Trials
NCT00239889Completed300
Marius Pharmaceuticals
1 program
1
IbuprofenPhase 3Small Molecule1 trial
Active Trials
NCT01567072Completed192Est. Sep 2016
Bioretec
BioretecFinland - Tampere
1 program
PLGA implant, Bioretec ltd. FinlandN/A1 trial
Active Trials
NCT03474900Completed35Est. Dec 2018
Novartis
NovartisBASEL, Switzerland
1 program
Salmon calcitoninPHASE_4

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
SandozSalmon calcitonin
Marius PharmaceuticalsIbuprofen
BioretecPLGA implant, Bioretec ltd. Finland

Clinical Trials (3)

Total enrollment: 527 patients across 3 trials

NCT00239889SandozSalmon calcitonin

Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women

Start: Mar 2002300 patients
Phase 4Completed

Non Steroidal Antiinflammatory Drugs Influence on Heal of Distal Radius Fracture

Start: Apr 2012Est. completion: Sep 2016192 patients
Phase 3Completed
NCT03474900BioretecPLGA implant, Bioretec ltd. Finland

Biodegradable Versus Titanium Nailing in Forearm Shaft Fractures in Children

Start: Feb 2011Est. completion: Dec 201835 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.